Advertisement
Advertisement
U.S. markets open in 1 hour 5 minutes
Advertisement
Advertisement
Advertisement
Advertisement

OpGen, Inc. (OPGN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.2862-0.0905 (-24.02%)
At close: 04:00PM EDT
0.2800 -0.01 (-2.17%)
Pre-Market: 08:15AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Bollinger Bands

Bollinger Bands

Previous Close0.3767
Open0.3400
Bid0.2720 x 1100
Ask0.0000 x 1400
Day's Range0.2695 - 0.3573
52 Week Range0.2695 - 3.5500
Volume1,446,409
Avg. Volume310,401
Market Cap13.831M
Beta (5Y Monthly)-0.38
PE Ratio (TTM)N/A
EPS (TTM)-0.8290
Earnings DateNov 09, 2022 - Nov 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.84
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for OPGN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • OpGen, Inc.
    Analyst Report: Becton, Dickinson And Co.Headquartered in Franklin Lakes, New Jersey, BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, industry, and the general public. Its operations consist of three worldwide business segments: BD Medical, BD Life Sciences, and BD Interventional.
    Rating
    Fair Value
    Economic Moat
    11 days agoArgus Research
View more
Advertisement
Advertisement